抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Remtolumab
All
TD-HS856096_1.jpg
- Catalog： TD-HS856096
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： Bispecific, A-1230717, ABT-122, CAS: 1791410-27-9
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Remtolumab
| Catalog No. | TD-HS856096 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer |
| Expression system | Mammalian Cells |
| Species | Human |
| Clonality | Monoclonal |
| Target | CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1 |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | Q16552 & P01375 |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternate Names | Bispecific, A-1230717, ABT-122, CAS: 1791410-27-9 |
| Background | Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|
|
Detects IL17A in indirect ELISAs. |